200 related articles for article (PubMed ID: 25955868)
1. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population.
Zahoor A; Mansoor Q; Farooqi AA; Fayyaz S; Naz G; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):108-12. PubMed ID: 26518902
[TBL] [Abstract][Full Text] [Related]
4. The Impact of TRAIL (C1595T and G1525A) and DR4 (rs20576) Gene Polymorphisms on Systemic Lupus Erythematosus.
Sandoughi M; Salimi S; Shahraki-Ghadimi H; Saravani M
Biochem Genet; 2020 Aug; 58(4):649-659. PubMed ID: 32342239
[TBL] [Abstract][Full Text] [Related]
5. Association between laryngeal squamous cell carcinoma and polymorphisms in tumor necrosis factor related apoptosis induce ligand (TRAIL), TRAIL receptor and sTRAIL levels.
Verim A; Turan S; Farooqi AA; Kahraman OT; Tepe-Karaca C; Yildiz Y; Naiboglu B; Ozkan NE; Ergen A; Isitmangil GA; Yaylim I
Asian Pac J Cancer Prev; 2014; 15(24):10697-703. PubMed ID: 25605161
[TBL] [Abstract][Full Text] [Related]
6. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
[TBL] [Abstract][Full Text] [Related]
7. [Correlations of genetic polymorphisms of tumor necrosis factor-related apoptosis-inducing ligand gene and its plasma phenotype with ulcerative colitis].
Jiang Y; Lin XQ; Cao SG; Xu CL; Wang JZ; Huang ZM; Chen XR; Song L; Xue ZX
Zhonghua Yi Xue Za Zhi; 2012 May; 92(18):1244-8. PubMed ID: 22883061
[TBL] [Abstract][Full Text] [Related]
8. Association between the TRAIL single nucleotide polymorphism rs1131580 and type 2 diabetes mellitus in a Han Chinese population.
Yu MY; Zhao PQ; Yan XH; Liu B; Zhang QQ; Wang R; Ma CH; Liang XH; Zhu FL; Gao LF
Genet Mol Res; 2013 Sep; 12(3):3455-64. PubMed ID: 24065684
[TBL] [Abstract][Full Text] [Related]
9. Association of the polymorphism of DR4 with the risk and severity of lumbar disc degeneration in the Chinese Han population.
Tan H; Zhao J; Jiang J; Ren Y
Scand J Clin Lab Invest; 2012 Nov; 72(7):576-9. PubMed ID: 23050498
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK
J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308
[TBL] [Abstract][Full Text] [Related]
11. [Associations of Crohn's disease with DR4 and DR5 gene polymorphisms].
Lin X; Jin L; Pan C; Zheng S; Zhang D; Lin X; Ding R; Jiang L; Jiang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):715-22. PubMed ID: 26418999
[TBL] [Abstract][Full Text] [Related]
12. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels.
Kim H; Ku SY; Suh CS; Kim SH; Kim JH; Kim JG
Arch Gynecol Obstet; 2012 Jul; 286(1):147-53. PubMed ID: 22392486
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
[TBL] [Abstract][Full Text] [Related]
14. Digging more in the genetic risk prediction of hepatitis C virus epidemic in Egypt: Apoptosis genes polymorphisms in the susceptibility of hepatitis C virus and association with viral load.
Khalifa RH; Shahin RMH; Aboukhalil REE; Marie MA; El-Deeb AM; Riad NM
Virus Res; 2017 Jun; 238():35-39. PubMed ID: 28587866
[TBL] [Abstract][Full Text] [Related]
15. Association Between C1q, TRAIL, and Tim-1 Gene Polymorphisms and Systemic Lupus Erythematosus.
Yu Y; Zhu C; Zhou S; Chi S
Genet Test Mol Biomarkers; 2018 Sep; 22(9):546-553. PubMed ID: 30183357
[TBL] [Abstract][Full Text] [Related]
16. Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians.
Mittal RD; Srivastava P; Mittal T; Verma A; Jaiswal PK; Singh V; Mandal RK; Mandhani A
Eur J Surg Oncol; 2011 Aug; 37(8):727-33. PubMed ID: 21700414
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
18. Death receptor 4 variants and colorectal cancer risk.
Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-related apoptosis inducing ligand gene polymorphisms are correlated with gastric cancer in central China.
Wang C; Xu S; Yi F; Wang X; Lei Y; Huang S; Zhou R; Xia B
Pharm Res; 2015 Mar; 32(3):762-8. PubMed ID: 24277417
[TBL] [Abstract][Full Text] [Related]
20. Death receptor 4 and bladder cancer risk.
Hazra A; Chamberlain RM; Grossman HB; Zhu Y; Spitz MR; Wu X
Cancer Res; 2003 Mar; 63(6):1157-9. PubMed ID: 12649168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
